Business Context and Reporting Period
Company: LeMaitre Vascular, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 30, 2014
Event: Entry into a Material Definitive Agreement for a public offering of common stock.
Key Financial Metrics
This filing details a capital raise rather than operational performance metrics. Key figures include:
- Shares Offered (Firm): 1,430,000 shares of common stock.
- Offering Price: $7.00 per share.
- Over-Allotment Option: Up to 214,500 additional shares exercisable within 30 days.
- Expected Net Proceeds (Base): Approximately $9.1 million (excluding underwriting discounts and expenses).
- Expected Net Proceeds (Full Exercise): Approximately $10.5 million if the over-allotment option is fully exercised.
- Expected Closing Date: June 4, 2014.
Note: The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The primary material change is the execution of an underwriting agreement with Canaccord Genuity Inc. and Stifel, Nicolaus & Company, Incorporated. This agreement facilitates the public offering of equity to raise capital. The filing references an effective registration statement on Form S-3 filed on May 2, 2014.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on May 30, 2014, announcing the pricing of the offering. The offering is subject to customary closing conditions.
Risks and Contingencies: The Underwriting Agreement contains customary representations, warranties, indemnification obligations, and termination provisions. The closing is contingent upon the satisfaction of customary conditions.
Investor Verification Checklist
- Verify the final closing date of the offering (expected June 4, 2014).
- Confirm whether the underwriters exercise the 30-day over-allotment option for 214,500 shares.
- Review the final net proceeds after deducting actual underwriting discounts and offering expenses.
- Examine the full Underwriting Agreement (Exhibit 1.1) for specific termination rights and indemnification details.
- Check subsequent filings for the use of proceeds and impact on diluted share count.